Raymond James Financial
CTSO icon

Raymond James Financial’s Cytosorbents Corp CTSO Stock Holding History

Raymond James Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61K Sell
107,751
-951
-0.9% -$649 ﹤0.01% 5098
2025
Q4 		$69.5K Sell
108,702
-19
-0% -$15 ﹤0.01% 4976
2025
Q3 		$102K Buy
108,721
+132
+0.1% +$130 ﹤0.01% 4748
2025
Q2 		$139K Sell
108,589
-1,751
-2% -$1.76K ﹤0.01% 4703
2025
Q1 		$110K Buy
110,340
+1,719
+2% +$1.81K ﹤0.01% 4534
2024
Q4 		$98.8K Buy
+108,621
New +$107K ﹤0.01% 4530

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Raymond James Financial's CTSO Position: Q1 2026 in Review

Raymond James Financial reduced its Cytosorbents Corp (CTSO) stake by 0.87% in Q1 2026, selling an estimated $649 and leaving 107,751 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #5098.

Raymond James Financial first reported a position in CTSO in Q4 2024 and has held it in 6 quarters since. The position peaked at $139K in Q2 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Raymond James Financial held 107,751 shares of Cytosorbents Corp worth $61K as of Q1 2026.
  • Raymond James Financial sold 951 Cytosorbents Corp shares in Q1 2026, an estimated $649.
  • Cytosorbents Corp made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5098 holding.
  • Raymond James Financial first reported a position in Cytosorbents Corp in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Cytosorbents Corp position peaked at $139K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.